Stock Events

Stock Events

Wesana Health 

C$0.010000
3
+C$0.00+0%Wednesday 13:39

Statistics

Day High
0.01
Day Low
0.01
52W High
0.01
52W Low
0.01
Volume
0
Avg. Volume
0
Mkt Cap
209,190
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-2.34MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.6B
Compass Pathways operates in the psychedelic medicine space, focusing on psilocybin therapy for depression, directly competing with Wesana's mental health treatment approaches.
AtaiBeckley
ATAI
Mkt Cap2.73B
ATAI Life Sciences is a biotech company with a focus on psychedelic and non-psychedelic compounds for mental health, making it a competitor in the same sector as Wesana.
GH Research
GHRS
Mkt Cap1.43B
GH Research is involved in the development of therapeutic solutions using psychedelic substances for mental health disorders, competing in Wesana's market.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness provides psychedelic therapy and research, making it a competitor in the mental health treatment market where Wesana operates.
MiniMed Group
MMED
Mkt Cap5.14B
MindMed develops medicines based on psychedelic substances, targeting mental health issues similar to Wesana's focus, making them competitors.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics is exploring the use of psychedelics for treatments in mental health and addiction, areas Wesana Health is also targeting.
Noveris Health Sciences
MYCOF
Mkt Cap42.74M
Mydecine Innovations Group focuses on developing and commercializing psychedelic medicines, including for mental health, competing with Wesana Health.

About

Wesana Health Holdings Inc. is a life sciences firm dedicated to advancing and providing psychedelic-based therapies, including psilocybin-enhanced psychotherapy, primarily targeting the treatment of traumatic brain injuries (TBI). The company focuses on pioneering scientifically validated compounds and therapeutic strategies. Its mission is to enable patients suffering from trauma-related neurological, psychological, and mental health conditions to achieve recovery. Wesana Health is headquartered in Chicago, Illinois.
Show More
CEO
Daniel Carcillo
Employees
7
Country
Canada
ISIN
CA95081C1059
WKN
000A3CMTQ

Listings

MU
DE
DDX.MU
OTC Link
US
WSNAF
CN
CA
WESA-X.CN
CN
CA
WESA.CN

0 Comments

Share your thoughts

FAQs

What is Wesana Health stock price today?▼
The current price of WESA-X.CN is C$0.01 CAD — it has increased by +0% in the past 24 hours. Watch Wesana Health stock price performance more closely on the chart.
What is Wesana Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange Wesana Health stocks are traded under the ticker WESA-X.CN.
Is Wesana Health stock price growing?▼
WESA-X.CN stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Wesana Health has showed a +0% increase.
What is Wesana Health market cap?▼
Today Wesana Health has the market capitalization of 209,190
What is Wesana Health revenue for the last year?▼
Wesana Health revenue for the last year amounts to 0 CAD.
What is Wesana Health net income for the last year?▼
WESA-X.CN net income for the last year is -2.34M CAD.
How many employees does Wesana Health have?▼
As of November 2, 2026, the company has 7 employees.
In which sector is Wesana Health located?▼
Wesana Health operates in the Health & Wellness sector.
When did Wesana Health complete a stock split?▼
The last stock split for Wesana Health was on May 10, 2021 with a ratio of 1:28.1245577.
Where is Wesana Health headquartered?▼
Wesana Health is headquartered in Chicago, Canada.